Skip to main content

Table 1 Demographic, clinical and CSF characteristics by HIV status

From: Mortality in hospitalized patients with tuberculous meningitis

 

Total (n = 263)

HIV Positive (n = 100)

HIV Negative (n = 163)

p-value

Age (years)a

35 (18–84)

35 (18–74)

35 (18–84)

0.899

Male

191 (72.6%)

81 (81.0%)

110 (67.4%)

0.010

TB history

63 (24.0%)

34 (34.0%)

29 (17.8%)

0.002

MDR-TB history

6 (2.28%)

5 (5.0%)

1 (0.3%)

0.030

TB contact

70 (26.7%)

21 (21.0%)

49 (30.1%)

0.116

Alcoholism / Drug addiction

60 (22.8%)

34 (34.0%)

26 (15.9%)

0.001

Symptoms > 7 days

199 (76.1%)

82 (82.0%)

117 (71.8%)

0.075

Weight loss

129 (50.9%)

59 (59.6%)

70 (45.5%)

0.029

Headache

200 (79.1%)

81 (81.0%)

119/154 (77.3%)

0.431

Fever

182 (72.0%)

72 (72.0%)

110/154 (71.4%)

0.886

Altered level of Consciousness

173 (68.1%)

58 (58.0%)

115/155 (74.2%)

0.013

Focal neurologic deficits

91 (36.0%)

31 (31.3%)

60 (38.9%)

0.020

BMRC stage

 I

93 (35.3%)

39 (39.0%)

54 (33.1%)

0.502

 II

133 (50.6%)

46 (46.0%)

87 (53.4%)

 

 III

37 (14.1%)

15 (15.0%)

22 (13.5%)

 

 WBCb > 10,000 cells/uL

74/253 (29.3%)

15/99 (15.2%)

59/154 (38.3%)

< 0.001

 Hyponatremia

146/219 (66.7%)

64/85 (75.3%)

82/134 (61.2%)

0.039

 CD4 counta

 

60 (1–874)

  

 CD4 < 200

 

64/81 (79.0%)

  

 Detectable HIV Viral load

 

76/77 (98.7%)

  

CSF Analysis

 Proteina

213 (10–6000)

226 (12–1200)

210 (10–6000)

0.550

 Glucosea

32 (10–118)

33.2 (13.5–82)

31 (10–118)

0.595

 Leucocytesa

80 (1–3808)

56 (1–1550)

90 (1–3808)

0.040

 Mononuclear cells (%)a

98 (5–100)

100 (15–100)

95 (5–100)

0.010

 ADAa

10 (0.8–76.1)

9.8 (0.9–53.3)

10 (0.9–76.1)

0.974

  1. a Median (range), b White blood cell count